The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.
Oligometastasis, Metastatic Cancer
The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
-
Duke Cancer Institute Cary, Cary, North Carolina, United States, 27518
Durham Veterans Administration Health Care System (DVAHCS), Durham, North Carolina, United States, 27705
Duke University Medical Center, Durham, North Carolina, United States, 27710
Duke Women's Cancer Care Raleigh, Raleigh, North Carolina, United States, 27607
Duke Raleigh Hospital, Raleigh, North Carolina, United States, 27609
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Duke University,
Joseph Salama, MD, PRINCIPAL_INVESTIGATOR, Duke University
2029-09